Patient no. | Age (y) | Sex | Primary | Pathology | Confirmation | Clinical stage | 18F-FDG stage | 18F-TYR stage |
---|---|---|---|---|---|---|---|---|
1 | 75 | M | Lung | SCC | Biopsy | T4 N1 M0 | T+ N1 M0 | T+ N1 M0 |
2 | 77 | F | Lymphoma | LG NHL | Surgery | I | I | I |
3 | 72 | M | Lung | SCC | Surgery | T2 N0 M0 | T+ N0 M0 | T+ N0 M0 |
4 | 83 | F | Lung | LCC | Biopsy | T4 N1 Mx | T+ N1 M1 | T+ N1 M0 |
5 | 52 | M | Tongue | SCC | Biopsy | T4 N2 M0 | T+ N2 M0 | T+ N2 M0 |
6 | 77 | M | Lung | SCC | Biopsy | T1 N1 M0 | T+ N1 M0 | T+ N1 M0 |
7 | 68 | F | Lymphoma | HD | Biopsy | IV | IV | II |
8 | 67 | M | Lung | SCC | Biopsy | T4 N0 M0 | T+ N0 M0 | T+ N0 M0 |
9 | 65 | F | Lymphoma | IG NHL | Biopsy | IV | II | II |
10 | 69 | F | Tonsil | SCC | Surgery | T2 N0 M0 | T+ N0 M0 | T+ N0 M0 |
11 | 67 | M | Lung | LCC | Surgery | T2 N0 M0 | T+ N1 M0 | T+ N0 M0 |
12 | 63 | M | Lung | Adenoc. | Surgery | T2 N2 M0 | T+ N2 M0 | T+ N0 M0 |
13 | 56 | M | Lymphoma | LG NHL | Biopsy | IIIA | III | III |
14 | 72 | M | Lymphoma | HG NHL | Biopsy | IV | IV | II |
15 | 74 | M | Lymphoma | IG NHL | Biopsy | III | III | III (−) |
16 | 69 | M | Lung | SCC | Biopsy | T2 N0 M0 | T+ N0 M0 | T+ N0 M0 |
17 | 54 | M | Lung | Adenoc. | Surgery | T1 N0 M0 | T+ N0 M0 | T+ N0 M0 |
18 | 71 | F | Lymphoma | LG NHL | Biopsy | IA | FN | FN |
19* | 52 | F | Lung | SCC | Surgery | T1 N0 M1 | T+ N0 M0 | FN |
20 | 59 | M | Lung | Adenoc. | Surgery | T1 N0 M0 | T+ N1 M0 | T+ N0 M0 |
21 | 64 | F | Lymphoma | LG NHL | Biopsy | IA | I | I |
22 | 74 | M | Lymphoma | HG NHL | Biopsy | IIIB | III | III (−) |
23 | 67 | M | Lymphoma | HD | Biopsy | IIB | II | II |
↵* Metastasis was located in brain, which was not included in 18F-FDG or 18F-TYR study.
SCC = squamous cell carcinoma; LG = low grade; LCC = large cell carcinoma; HD = Hodgkin’s disease; IG = intermediate grade; Adenoc. = adenocarcinoma; HG = high grade; (−) = fewer lesions were visualized; FN = false-negative.
Clinical stages obtained using conventional methods or after surgery are given according to American Joint Committee on Cancer.